Tesamorelin is a synthetic analog of human growth hormone-releasing hormone (GHRH), consisting of the full 44-amino acid GHRH(1-44) sequence with a trans-3-hexenoic acid group conjugated at the N-terminus. This modification was designed to improve enzymatic stability and extend the pharmacokinetic profile compared to native GHRH. In preclinical and experimental research, Tesamorelin is used as a model compound for studying GHRH receptor (GHRHR) activation, pulsatile growth hormone secretion dynamics, and somatotroph cell responsiveness. Laboratory models investigate its binding affinity, signal transduction cascades, and effects on IGF-1 axis regulation under controlled experimental conditions. Published research describes Tesamorelin in studies examining neuroendocrine feedback loops, pituitary function markers, and body composition-related metabolic signaling in animal models. Its structural relationship to native GHRH, combined with enhanced stability, positions it as a research tool for investigating sustained GHRH receptor engagement. Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S₁ Molecular Weight: ~5135.9 Da CAS: 218949-48-5 Supplied for laboratory research applications only. Not for human consumption.